Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:253-260

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mori, T. A.
Right arrow Articles by Beilin, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mori, T. A.
Right arrow Articles by Beilin, L. J.
Related Collections
Right arrow Nutrition
Right arrow Lipids
Right arrow Other hypertension

(Hypertension. 1999;34:253-260.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Docosahexaenoic Acid but Not Eicosapentaenoic Acid Lowers Ambulatory Blood Pressure and Heart Rate in Humans

Trevor A. Mori; Danny Q. Bao; Valerie Burke; Ian B. Puddey; Lawrence J. Beilin

From the Department of Medicine, University of Western Australia, and the West Australian Heart Research Institute, Perth, Australia.

Abstract—Animal studies suggest that the 2 major {omega}3 fatty acids found in fish, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may have differential effects on blood pressure (BP) and heart rate (HR). The aim of this study was to determine whether there were significant differences in the effects of purified EPA or DHA on ambulatory BP and HR in humans. In a double-blind, placebo-controlled trial of parallel design, 59 overweight, mildly hyperlipidemic men were randomized to 4 g/d of purified EPA, DHA, or olive oil (placebo) capsules and continued their usual diets for 6 weeks. Fifty-six subjects completed the study. Only DHA reduced 24-hour and daytime (awake) ambulatory BP (P<0.05). Relative to the placebo group, 24-hour BP fell 5.8/3.3 (systolic/diastolic) mm Hg and daytime BP fell 3.5/2.0 mm Hg with DHA. DHA also significantly reduced 24-hour, daytime, and nighttime (asleep) ambulatory HRs (P=0.001). Relative to the placebo group, DHA reduced 24-hour HR by 3.5±0.8 bpm, daytime HR by 3.7±1.2 bpm, and nighttime HR by 2.8±1.2. EPA had no significant effect on ambulatory BP or HR. Supplementation with EPA increased plasma phospholipid EPA from 1.66±0.07% to 9.83±0.06% (P<0.0001) but did not change DHA levels. Purified DHA capsules increased plasma phospholipid DHA levels from 4.00±0.27% to 10.93±0.62% (P<0.0001) and led to a small, nonsignificant increase in EPA (1.52±0.12% to 2.26±0.16%). Purified DHA but not EPA reduced ambulatory BP and HR in mildly hyperlipidemic men. The results of this study suggest that DHA is the principal {omega}3 fatty acid in fish and fish oils that is responsible for their BP- and HR-lowering effects in humans. These results have important implications for human nutrition and the food industry.


Key Words: eicosapentaenoic acid • docosahexaenoic acid • fatty acids • blood pressure • heart rate




This article has been cited by other articles:


Home page
HypertensionHome page
B. Valera, E. Dewailly, and P. Poirier
Environmental Mercury Exposure and Blood Pressure Among Nunavik Inuit Adults
Hypertension, November 1, 2009; 54(5): 981 - 986.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
J. H. Rennison and D. R. Van Wagoner
Impact of Dietary Fatty Acids on Cardiac Arrhythmogenesis
Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 460 - 469.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
J. W. Fetterman Jr. and M. M. Zdanowicz
Therapeutic potential of n-3 polyunsaturated fatty acids in disease
Am. J. Health Syst. Pharm., July 1, 2009; 66(13): 1169 - 1179.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. K. Gabler, J. D. Spencer, D. M. Webel, and M. E. Spurlock
In Utero and Postnatal Exposure to Long Chain (n-3) PUFA Enhances Intestinal Glucose Absorption and Energy Stores in Weanling Pigs
J. Nutr., November 1, 2007; 137(11): 2351 - 2358.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Yagil and Y. Yagil
Peroxisome Proliferator-Activated Receptor {alpha}: Friend or Foe?
Hypertension, November 1, 2007; 50(5): 847 - 850.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
A. Prabodh Shah, A. M. Ichiuji, J. K. Han, M. Traina, A. El-Bialy, S. Kamal Meymandi, and R. Yvonne Wachsner
Cardiovascular and Endothelial Effects of Fish Oil Supplementation in Healthy Volunteers
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 213 - 219.
[Abstract] [PDF]


Home page
J. Nutr.Home page
H. E. Theobald, A. H. Goodall, N. Sattar, D. C. S. Talbot, P. J. Chowienczyk, and T. A. B. Sanders
Low-Dose Docosahexaenoic Acid Lowers Diastolic Blood Pressure in Middle-Aged Men and Women
J. Nutr., April 1, 2007; 137(4): 973 - 978.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
L. J. Schwellenbach, K. L. Olson, K. J. McConnell, R. S. Stolcpart, J. D. Nash, J. A. Merenich, and for the Clinical Pharmacy Cardiac Risk Service Stu
The Triglyceride-Lowering Effects of a Modest Dose of Docosahexaenoic Acid Alone Versus in Combination with Low Dose Eicosapentaenoic Acid in Patients with Coronary Artery Disease and Elevated Triglycerides
J. Am. Coll. Nutr., December 1, 2006; 25(6): 480 - 485.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
O. A. Gudbrandsen, M. Hultstrom, S. Leh, L. Monica Bivol, O. Vagnes, R. K. Berge, and B. M. Iversen
Prevention of Hypertension and Organ Damage in 2-Kidney, 1-Clip Rats by Tetradecylthioacetic Acid
Hypertension, September 1, 2006; 48(3): 460 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Larnkjaer, J. H. Christensen, K. F. Michaelsen, and L. Lauritzen
Maternal Fish Oil Supplementation during Lactation Does Not Affect Blood Pressure, Pulse Wave Velocity, or Heart Rate Variability in 2.5-y-old Children
J. Nutr., June 1, 2006; 136(6): 1539 - 1544.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Mozaffarian, A. Geelen, I. A. Brouwer, J. M. Geleijnse, P. L. Zock, and M. B. Katan
Effect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials
Circulation, September 27, 2005; 112(13): 1945 - 1952.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Michalsen and G. J. Dobos
Heart rate reduction through lifestyle modification
Eur. Heart J., September 1, 2005; 26(17): 1806 - 1807.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Geelen, I. A Brouwer, E. G Schouten, A. C Maan, M. B Katan, and P. L Zock
Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 416 - 420.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. D Stark and B. J Holub
Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy
Am. J. Clinical Nutrition, May 1, 2004; 79(5): 765 - 773.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. G Owen, P. H Whincup, J. A Gilg, and D. G Cook
Effect of breast feeding in infancy on blood pressure in later life: systematic review and meta-analysis
BMJ, November 22, 2003; 327(7425): 1189 - 1195.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Dallongeville, J. Yarnell, P. Ducimetiere, D. Arveiler, J. Ferrieres, M. Montaye, G. Luc, A. Evans, A. Bingham, B. Hass, et al.
Fish Consumption Is Associated With Lower Heart Rates
Circulation, August 19, 2003; 108(7): 820 - 825.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J S Forsyth, P Willatts, C Agostoni, J Bissenden, P Casaer, and G Boehm
Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomised controlled trial
BMJ, May 3, 2003; 326(7396): 953 - 953.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. J. Woodman, T. A. Mori, V. Burke, I. B. Puddey, G. F. Watts, J. D. Best, and L. J. Beilin
Docosahexaenoic Acid But Not Eicosapentaenoic Acid Increases LDL Particle Size in Treated Hypertensive Type 2 Diabetic Patients
Diabetes Care, January 1, 2003; 26(1): 253 - 253.
[Full Text] [PDF]


Home page
HypertensionHome page
Q. N. Diep, F. Amiri, R. M. Touyz, J. S. Cohn, D. Endemann, M. F. Neves, and E. L. Schiffrin
PPAR{alpha} Activator Effects on Ang II-Induced Vascular Oxidative Stress and Inflammation
Hypertension, December 1, 2002; 40(6): 866 - 871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. J Woodman, T. A Mori, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin
Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension
Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1007 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.P.M Leeson, A Mann, M Kattenhorn, J.E Deanfield, A Lucas, and D.P.R Muller
Relationship between circulating n-3 fatty acid concentrations and endothelial function in early adulthood
Eur. Heart J., February 1, 2002; 23(3): 216 - 222.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
B. M. Curtis and J. H. O'Keefe Jr
Autonomic Tone as a Cardiovascular Risk Factor: The Dangers of Chronic Fight or Flight
Mayo Clin. Proc., January 1, 2002; 77(1): 45 - 54.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
M. Y Abeywardena and R. J Head
Longchain n-3 polyunsaturated fatty acids and blood vessel function
Cardiovasc Res, December 1, 2001; 52(3): 361 - 371.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T Holm, A.K Andreassen, P Aukrust, K Andersen, O.R Geiran, J Kjekshus, S Simonsen, and L Gullestad
Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients
Eur. Heart J., March 1, 2001; 22(5): 428 - 436.
[Abstract] [PDF]


Home page
J. Nutr.Home page
J.-M. R. Frenoux, E. D. Prost, J. L. Belleville, and J. L. Prost
A Polyunsaturated Fatty Acid Diet Lowers Blood Pressure and Improves Antioxidant Status in Spontaneously Hypertensive Rats
J. Nutr., January 1, 2001; 131(1): 39 - 45.
[Abstract] [Full Text]


Home page
Complementary Health Practice ReviewHome page
M. G. Warner
Complementary and Alternative Therapies for Hypertension
Complementary Health Practice Review, October 1, 2000; 6(1): 11 - 19.
[PDF]


Home page
CirculationHome page
T. A. Mori, G. F. Watts, V. Burke, E. Hilme, I. B. Puddey, and L. J. Beilin
Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Vascular Reactivity of the Forearm Microcirculation in Hyperlipidemic, Overweight Men
Circulation, September 12, 2000; 102(11): 1264 - 1269.
[Abstract] [Full Text] [PDF]